Amedeo Smart

Free Medical Literature Service



Cytomegalovirus Infection

  Free Subscription

Articles published in
Clin Transplant
    March 2022
  1. HIDAKA Y, Goto N, Yamanaga S, Kinoshita K, et al
    Two-year outcomes of low-exposure extended-release tacrolimus and mycophenolate mofetil regimen in de novo kidney transplantation: A multi-center randomized controlled trial.
    Clin Transplant. 2022 Mar 28:e14655. doi: 10.1111/ctr.14655.
    >> Share

  2. NGUYEN A, Finci L, Berney T, Tonoli D, et al
    Letermovir for cytomegalovirus primary prophylaxis in a multiple abdominal/ small bowel transplant recipient.
    Clin Transplant. 2022 Mar 2:e14624. doi: 10.1111/ctr.14624.
    >> Share

    January 2022
  3. MEHTA RB, Shimko K, Zhang X, Puttarajappa C, et al
    Rabbit antithymocyte globulin dose and early subclinical and clinical rejections in kidney transplantation.
    Clin Transplant. 2022 Jan 9:e14582. doi: 10.1111/ctr.14582.
    >> Share

  4. BRAR S, Berry R, Raval AD, Tang Y, et al
    Outcomes among CMV-mismatched and highly sensitized kidney transplants recipients who develop neutropenia.
    Clin Transplant. 2022 Jan 4:e14583. doi: 10.1111/ctr.14583.
    >> Share

    December 2021
  5. AFZAL A, Alam A, van Zyl JS, Zafar H, et al
    Observed Elevated Donor-Derived Cell Free DNA in Orthotopic Heart Transplant Recipients Without Clinical Evidence of Rejection.
    Clin Transplant. 2021 Dec 4:e14549. doi: 10.1111/ctr.14549.
    >> Share

    November 2021
  6. ORTIZ F, Lempinen M, Aaltonen S, Koivuviita N, et al
    Letermovir treatment for CMV infection in kidney and pancreas transplantation: a valuable option for complicated cases.
    Clin Transplant. 2021 Nov 19:e14537. doi: 10.1111/ctr.14537.
    >> Share

    July 2021
  7. JORGENSON MR, Descourouez JL, Leverson GE, Saddler CM, et al
    A Pilot Study of an Intensified Ganciclovir Dosing Strategy for Treatment of Cytomegalovirus Disease in Kidney and/or Pancreas Transplant Recipients.
    Clin Transplant. 2021 Jul 15. doi: 10.1111/ctr.14427.
    >> Share

    June 2021
  8. RHO E, Naf B, Tf M, Rp W, et al
    Use of Letermovir-Valganciclovir combination as a step-down treatment after Foscarnet for Ganciclovir-resistant CMV infection in kidney transplant recipients.
    Clin Transplant. 2021 Jun 28. doi: 10.1111/ctr.14401.
    >> Share

  9. JORGENSON MR, Marka N, Leverson GE, Smith JA, et al
    Valganciclovir Prophylaxis Extension from 3 to 6 Months in High Risk Pancreas Transplant Recipients Does Not Impact Incidence of Cytomegalovirus Infection at 12 months.
    Clin Transplant. 2021 Jun 2:e14379. doi: 10.1111/ctr.14379.
    >> Share

    May 2021
  10. DURST MM, Jorgenson MR, Descourouez JL, Saddler CM, et al
    Bimonthly viral monitoring for late-onset cytomegalovirus infection-Balancing efficacy with patient palatability; A reply to Melgarejo et al.
    Clin Transplant. 2021 May 21:e14348. doi: 10.1111/ctr.14348.
    >> Share

    March 2021
  11. VEIT T, Pan M, Munker D, Arnold P, et al
    Association of CMV-specific-T-cell immunity and risk of CMV infection in lung transplant recipients.
    Clin Transplant. 2021 Mar 22:e14294. doi: 10.1111/ctr.14294.
    >> Share

  12. RAHIMISHAHMIRZADI M, Jevnikar AM, House AA, Luke PP, et al
    Late-onset Allograft Rejection, Cytomegalovirus Infection and Renal Allograft Loss: Is Anti-CMV Prophylaxis Required Following Late-onset Allograft Rejection?
    Clin Transplant. 2021 Mar 13:e14285. doi: 10.1111/ctr.14285.
    >> Share

    February 2021
  13. MELGAREJO I, Jorgensen D, Hariharan S, Puttarajappa CM, et al
    Bimonthly Viral Monitoring for Late-Onset Cytomegalovirus infection in Kidney Transplant Recipients.
    Clin Transplant. 2021 Feb 19:e14259. doi: 10.1111/ctr.14259.
    >> Share

    January 2021
  14. VON STEIN L, Leino AD, Pesavento T, Rajab A, et al
    Antithymocyte induction dosing and incidence of opportunistic viral infections using steroid-free maintenance immunosuppression.
    Clin Transplant. 2021;35:e14102.
    >> Share

    April 2020
  15. ANDERSON A, Raja M, Vazquez N, Morris M, et al
    Clinical "real-world" experience with letermovir for prevention of cytomegalovirus infection in allogeneic hematopoietic cell transplant recipients.
    Clin Transplant. 2020 Apr 3:e13866. doi: 10.1111/ctr.13866.
    >> Share

    March 2020
  16. LAUB MR, Byrns J, Gommer J, Ellis M, et al
    Delayed versus initial cytomegalovirus prophylaxis after kidney transplantation.
    Clin Transplant. 2020 Mar 12:e13854. doi: 10.1111/ctr.13854.
    >> Share

    January 2020
  17. JORGENSON MR, Descourouez JL, Lyu B, Astor BC, et al
    Management of BK Viremia is Associated with a Lower Risk of Subsequent Cytomegalovirus Infection in Kidney Transplant Recipients.
    Clin Transplant. 2020 Jan 29:e13798. doi: 10.1111/ctr.13798.
    >> Share

    November 2019
  18. ASANTE-KORANG A, Carapellucci J, Krasnopero D, Brown B, et al
    Resource Utilization of Cytomegalovirus Immune Globulin in Prevention and Treatment of Cytomegalovirus infection in Pediatric Heart Transplantation.
    Clin Transplant. 2019 Nov 6. doi: 10.1111/ctr.13750.
    >> Share

    March 2019
  19. HEMMERSBACH-MILLER M, Alexander BD, Sudan DL, Pieper C, et al
    Infections after Kidney Transplantation. Does Age Matter?
    Clin Transplant. 2019 Mar 8:e13516. doi: 10.1111/ctr.13516.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016